Familial Adenomatous Polyposis (FAP) is a hereditary condition that results in the early development of polyps and colorectal cancer that could starts at the early age of 12 years old. FAP is considered as an orphan disease, with a prevalence of 0,6/1,0 out of 10.000. Caused by germline mutations in the APC gene it is characterized by the development of hundreds to thousands of polyps and carriers of the APC gene mutation, if not treated appropriately, will develop colorectal cancer. Unfortunately at the moment there is no safe treatment available.
Promising fish oil-based coronavirus treatment heads to clinical
What is FAP Kdpharma Group
Daniele Polettini on LinkedIn: KD Pharma CDMO Division
Justin Slagel, Author at SLA Pharma AG
KD Pharma Group - capiton
Leader in Pharmaceutical Omega 3 Manufacturing
Treatments containing fish oil, omega-3 fatty acids being trialed
KD-PHARMA-GROUP-SA
KD Pharma Company Profile: Valuation, Funding & Investors
Leader in Pharmaceutical Omega 3 Manufacturing
Leader in Pharmaceutical Omega 3 Manufacturing
KD Pharma Group - capiton
